Literature DB >> 16730907

Biophysical characteristics of neurotensin polyplex for in vitro and in vivo gene transfection.

Martha L Arango-Rodriguez1, Ivan Navarro-Quiroga, Juan A Gonzalez-Barrios, Daniel B Martinez-Arguelles, Michael J Bannon, Juan Kouri, Patricia Forgez, William Rostene, Refugio Garcia-Villegas, Ismael Jimenez, Daniel Martinez-Fong.   

Abstract

Previously we improved the neurotensin (NT)-polyplex by the coupling of HA2 fusogenic peptide (FP) and Vp1 SV40 karyophilic peptide (KP). We now report the proportion of [(125)I]-NT, [(3)H]-FP, and poly-l-lysine (PLL) in the NT-polyplex, and some of its biophysical properties. We concluded that the most efficient NT-polyplex comprised 1 NT, 4 FP, and 2 PLL molecules. Electrophoresis revealed that high acidity is detrimental for NT-polyplex stability. Electron microscopy and electrophoresis studies showed that 6 muM KP and 1% serum condensed the plasmid DNA (pDNA) before the appearance of toroid structures. Four plasmids were used to evaluate the transfection efficiency. In vitro, maximum expression was produced at molar ratios (pDNA : [(125)I]-NT-[(3)H]-FP-PLL conjugate) of 1:34 for pEGFP-N1 and 1:27 for pECFP-Nuc. Cotransfection of those plasmids was attained at their optimum molar ratios. In vivo, maximum expression of the pDAT-BDNF-flag in dopamine neurons was produced at a 1:45 molar ratio, whereas that of pDAT-EGFP was at 1:20. The NT-polyplex in the presence of 1 muM SR-48692, an NT-receptor specific antagonist, and untargeted polyplex did not cause transfection in vivo demonstrating the specificity of gene transfer via NT-receptor endocytosis. This information is essential for synthesizing an efficient NT-polyplex that can provide a useful tool for specific gene transfection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16730907     DOI: 10.1016/j.bbagen.2006.02.021

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

1.  Neuron-specific delivery of nucleic acids mediated by Tet1-modified poly(ethylenimine).

Authors:  In-Kyu Park; Jurate Lasiene; Shinn-Huey Chou; Philip J Horner; Suzie H Pun
Journal:  J Gene Med       Date:  2007-08       Impact factor: 4.565

2.  Vitamin B12-impaired metabolism produces apoptosis and Parkinson phenotype in rats expressing the transcobalamin-oleosin chimera in substantia nigra.

Authors:  Carlos Enrique Orozco-Barrios; Shyue-Fang Battaglia-Hsu; Martha Ligia Arango-Rodriguez; Jose Ayala-Davila; Celine Chery; Jean-Marc Alberto; Henry Schroeder; Jean-Luc Daval; Daniel Martinez-Fong; Jean-Louis Gueant
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

Review 3.  Non-viral gene therapy for spinal cord regeneration.

Authors:  Li Yao; Sheng Yao; William Daly; William Hendry; Anthony Windebank; Abhay Pandit
Journal:  Drug Discov Today       Date:  2012-05-24       Impact factor: 7.851

4.  The Internalization of Neurotensin by the Low-Affinity Neurotensin Receptors (NTSR2 and vNTSR2) Activates ERK 1/2 in Glioma Cells and Allows Neurotensin-Polyplex Transfection of tGAS1.

Authors:  Alberto E Ayala-Sarmiento; Daniel Martinez-Fong; José Segovia
Journal:  Cell Mol Neurobiol       Date:  2015-03-14       Impact factor: 5.046

Review 5.  Overcoming barriers in non-viral gene delivery for neurological applications.

Authors:  Aaron Tasset; Arjun Bellamkonda; Wenliang Wang; Ilya Pyatnitskiy; Deidra Ward; Nicholas Peppas; Huiliang Wang
Journal:  Nanoscale       Date:  2022-03-10       Impact factor: 8.307

Review 6.  NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease.

Authors:  Daniel Martinez-Fong; Michael J Bannon; Louis-Eric Trudeau; Juan A Gonzalez-Barrios; Martha L Arango-Rodriguez; Nancy G Hernandez-Chan; David Reyes-Corona; Juan Armendáriz-Borunda; Ivan Navarro-Quiroga
Journal:  Nanomedicine       Date:  2012-03-07       Impact factor: 5.307

7.  Neurotensin receptor 1 is expressed in gastrointestinal stromal tumors but not in interstitial cells of Cajal.

Authors:  Petra Gromova; Brian P Rubin; An Thys; Christophe Erneux; Jean-Marie Vanderwinden
Journal:  PLoS One       Date:  2011-02-18       Impact factor: 3.240

8.  The transfection of BDNF to dopamine neurons potentiates the effect of dopamine D3 receptor agonist recovering the striatal innervation, dendritic spines and motor behavior in an aged rat model of Parkinson's disease.

Authors:  Luis F Razgado-Hernandez; Armando J Espadas-Alvarez; Patricia Reyna-Velazquez; Arturo Sierra-Sanchez; Veronica Anaya-Martinez; Ismael Jimenez-Estrada; Michael J Bannon; Daniel Martinez-Fong; Jorge Aceves-Ruiz
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

9.  Optimizing NTS-polyplex as a tool for gene transfer to cultured dopamine neurons.

Authors:  Daniel Hernandez-Baltazar; Daniel Martinez-Fong; Louis-Eric Trudeau
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

10.  Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy.

Authors:  Zherui Wu; Daniel Martinez-Fong; Jean Trédaniel; Patricia Forgez
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-17       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.